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Abstract
Background: Rift valley fever (RVF) is a mosquito-borne viral disease of domestic livestock and wild ruminants. In
camels RVF may cause abortion among pregnant camels, but is most often asymptomatic among other camels.
In this study, a seroepidemiological survey was conducted to determine the prevalence of RVFV antibodies and
to identify the potential risk factors associated with RVFV seropositivity among the Sudanese one-humped camel
(Camelus dromedaries) in Khartoum State, Sudan. A cross sectional study was conducted in Khartoum State, Sudan, in a
total of 240 camels selected randomly from four localities. Sera sampled were tested for the presence of RVFV-specific
immunoglobulin G (IgG) antibodies using a competitive enzyme-linked immunosorbent assay (c-ELISA).
Results: RVFV seropositivity was recorded in 23 out of 240 animals, prevalence rate of 9.6 % among camels in
Khartoum State. Age (OR = 8.29, p-value = 0.04) and heavy rainfall (OR = 5.36, p value = 0.01) were recorded as
potential risk factors for contracting RVF.
Conclusions: Older age and heavy rainfall were considered as potential risk factors for seropositivity to RVF.
Surveillance for RVF among camels and distribution of mosquito vectors should continue to better understand
the clinical signs associated with RVFV infection in camels and provide public health authorities an opportunity
to anticipate and prepare for a possible RVF outbreak in Khartoum State, Sudan.
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Background
Rift Valley fever (RVF) is a mosquito-borne viral disease
that typically occurs in various areas of sub-Saharan
Africa, where virus activity varies from a low-level en-
zootic cycle to explosive outbreaks covering large areas
[1]. RVF is caused by RVF virus (RVFV), a member of
the phlebovirus genus in the family Bunyaviridae. Peri-
odically, RVFV spreads to other areas, including north-
ward into Egypt in 1977 and eastward across the Red
Sea into Saudi Arabia and Yemen in 2000 [2–6]. RVF
in livestock can be devastating to agricultural commu-
nities and causes almost fatal clinical disease among
young animals and high abortion rates among livestock
[7]. In contrast, RVF is asymptomatic in humans and
can cause a mild febrile illness. Few cases (1–2 %) pro-
gress to more severe disease, such as acute hepatitis,
encephalitis, retinitis and/or a hemorrhagic syndrome
[8]. The first outbreak of RVF in Sudan was reported
in 1973 among sheep and cattle in the White Nile
State [9]. Subsequently, RVFV was isolated from a
herd of cattle in Hilat Kuku, Khartoum North [9, 10].
Serologic surveys have detected RVFV antibodies in
various species of domestic livestock and in humans
from different States of the Sudan, including Nile Valley,
Khartoum, Kassala, El Gezira, Sennar, and White Nile
[1, 11–15]. A recent seroepidemiologic survey reported
a high prevalence of RVFV IgG among febrile patients
admitted to New Halfa Hospital in Kassala State, Sudan
[16]. New Halfa is an extensively irrigated agricultural
province, located approximately 500 km east of Khartoum
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State. The high prevalence of RVFV- specific IgG anti-
bodies suggested considerable circulation of RVFV in
Kassala State at a particular point in time in the past.
Currently, little is known about the prevalence of
RVF in livestock in Sudan and no information is avail-
able in regard to the potential risk factors associated
with RVF among the livestock in the country, including
the Sudanese dromedary camels. Circulation of RVFV
in camels and detection of RVFV-specific antibodies is
well documented in the different region of the African
continent, including Sudan, Saudi Arabia, Tanzania, South
Africa, Mauritania, Kenya, Niger and Nigeria [7, 17–27].
Thus, during RVFV infection, viremic camels can provide
virus for vector transmission to humans and highly sus-
ceptible young ruminants, particularly lambs [24, 28].
In addition, previously employed techniques for the de-
tection of RVFV antibodies in Sudanese camels includes
agar gel immunodiffusion test, which is far less sensi-
tive than ELISA assay and is complicated by cross reac-
tion with other phleboviruses. Therefore, the control of
RVF would be important in the Sudan given the large
numbers of camels in the country, and their importance
to the national economy and rural communities [1].
Most of the existing data about the epidemiology of
RVF in camels in the Sudan is old. We believe epidemi-
ologic studies, including implementation of improved
surveillance, are urgently needed to better predict and
respond to RVF outbreak among camels in the Sudan.
The objectives of the present study were to estimate
the prevalence of RVF, as determined by detection of
RVF-specific IgG antibodies, and to identify the potential
risk factors associated with the diseases among the one-
humped camel (Camelus dromedarius) in Khartoum
State, Sudan. This study would be expected to reduce the
impact on the livelihood of pastoral communities and
ultimately avoid disease spread in human population.
Methods
Study area
The study was conducted in Khartoum State during the
period from October 2014 to March 2015. The State
covers an area of approximately 20,971 square kilometers.
The State is located between latitudes 15° 8° - 16° 39° N
and longitudes 31° 36 - 34° 25 E in the semi desert tro-
pics. It is dominated by semi desert climate, which is
characterized by very hot/dry summer and cold winter.
The average temperature ranges from 21 °C in the winter
to 47 °C in the summer. The mean annual evaporation
rate is 7.7 mm/day, and the average relative humidity
ranges from 21 % to −38 %. Khartoum State is boarded
by the River Nile State in the north; Kassala States in the
east, North Kordufan in the west and Elgezera State to
the South. The total population of camels in the country
is approximately 4.6 million. The camel population of
Khartoum State is 6,585 as estimated by the Sudan
Ministry of Animal Resources, 2006. A map of the
localities included in the study area of Khartoum State
is presented in (Fig. 1).
Study design
A cross sectional study was conducted to estimate the
prevalence rate of RVFV-specific IgG antibodies in
camels and to investigate the potential risk factors asso-
ciated with the disease. A total of 240 camels were se-
lected randomly using multistage probability sampling
method. Four localities were randomly selected from all
seven localities in Khartoum State, Sudan, which in-
clude, Um Badah, Omdurman, Sherq Elnile and Bahri.
Two administration units were selected randomly from
each locality. Finally, simple random sampling was ap-
plied to choose the animals from each herd [29]. All
camels included in this study were aged over one year.
The study is reported in compliance with the STROBE
statement [30].
Questionnaire
A pre-tested structured questionnaire with the primary
objective of elucidating the multifactorial background of
disease was conducted in an interactive manner at all
selected herds. All animals included in this study were
subjected to a questionnaire, which was filled out by the
animal owners. The questionnaire include individual risk
factor attributes including age (younger animals <2 years,
older animals 2 years and above), sex (male, female),
breed (Anafi, western), body condition (emaciate, fat),
and management risk factor attributes including herd
size (small, medium, large), grazing system (nomadic,
semi-nomadic, stationary), rain fall (high, low), mosquito
vector (presence or absence), mosquito control (practiced
or not), vegetation (low, high), water bonds (presence or
absence), and the four localities included in the study.
Collection of blood samples
A total of 240 blood samples were collected from the
dromedary camels in the study area of Khartoum State,
Sudan. Serum samples were separated and were kept
frozen at -20 °C for detection of RVFV-specific IgG anti-
bodies using competitive enzyme-linked immunosorbent
assay (cELISA).
Competitive Enzyme-Linked Immunosorbent Assay (cELISA)
A competitive enzyme-linked immunosorbent assay
(cELISA) was performed, as described by Hassanain
et al. [16], using a commercially available RVFV antibody
cELISA Kit (IDVet, Rue Louis Pasteur, Grabels, France).
The sera were screened for RVFV-specific IgG anti-
bodies as described by the manufacturer’s specifications.
cELISA was performed in 96-well antigen-coated
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microplates. Unless stated otherwise, 50 microliters (μl)
test volumes were used in the cELISA assay. The incuba-
tions were performed for 15 min at room temperature
(23 ± 2 °C). The plates were washed three times with the
provided washing buffer. Briefly, aliquots of 50 μl test
sera as well as positive and negative controls sera were
transferred undiluted to the RVFV antigen coated plates,
using multi-channel pipette. After incubation, the plates
were washed, and 50 μl of antibody-peroxidase conju-
gate were added to each well. The plate was incubated at
15 min at room temperature. The plates were then
washed and 50 μl the substrate was added to each well.
The reaction was stopped using 50 μl of the stopping so-
lution. The results were read by using ELISA reader set
at 450 nm. A presumptive diagnosis was made when the
test samples produced an optical density < 50 % of the
mean of the negative controls. The test samples were
considered negative if the optical density ≥ 50 % of the
mean of the negative controls.
Statistical analyses
The data collected were entered into a computer on a
Microsoft Excel spread sheet. Statistical analysis was
performed using SPSS version 16 (for Windows) and
double checked before analyses. Associations between
the outcome variable (status of RVF seropositivity in
camels) and its potential risk factors were first screened
in a univariable analysis using Chi-square (χ2) test. A
multivariable model for the outcome variable was con-
structed using logistic regression analysis with enter
method for modeling checking. RVF was considered
as the dependent variable and the risk factors as in-
dependent variables. Finally, odd ratios and 95 % con-
fidence interval (CI) were calculated, and risk factors
with a p-value < 0.05 were taken as significant associ-
ation to RVF seropositivity.
Results
Using a cELISA assay, RVFV-specific IgG antibodies
were detected in 23 out of 240 camels included in the
study. The overall prevalence rate of RVFV antibodies
among camels in Khartoum State of Sudan was estimated
to be 9.6 %. The highest and lowest rates of RVFV sero-
positivity were recorded in Sherq Elnile and Omdurman,
respectively. The results of the univariate analysis using
chi-square test were presented in (Table 1). The final
model of RVFV infection indicated that only two inde-
pendent risk factors were statistically significant. Older
cattle (>2 years of age) were eight times more likely to
have been infected with RVF (OR = 8.29, CI = 1.05–9.66,
p-value = 0.04) compared to young animals (<2 years of
age). Heavy rainfall increased the risk of contracting RVF
compared to low rainfall (OR = 5.36, CI = 1.46–19.66,
p value = 0.01). Significant association between RVF
and potential risk factors in the final model were shown
in (Table 2). In contrast, there was no significant
Fig. 1 Map of State of Khartoum, Sudan showing the four localities included in the study
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association between RVF seropositive camels and the
animal sex, breed, grazing system, mosquito control,
herd size, body condition, introduction of new animal
to the herd, and localities.
Discussion
In recent years, the distribution and nature of RVF has
changed substantially. RVF has become of great veteri-
nary concern to dairy producers, wildlife managers and
veterinary diagnosticians because of the frequent occur-
rence of sporadic cases and outbreaks among domestic
and wild ruminants [1, 3, 5, 31–33]. Very little infor-
mation is available about the epidemiology and disease
potential of RVF in domestic livestock of the Sudan. The
prominent clinical sign in RFV infected camel is mainly
reflected by abortion storm [9]. Absence of clinically rec-
ognized symptoms of RVF infections with noticeable
outbreaks of abortion may lead to underestimation of
the importance of the disease in Sudanese camels. In
contrast, clinical signs other than abortions were re-
ported among camels in RVF outbreak in Mauritania,
including hemorrhagic septicemia and severe respira-
tory distress [26]. This observation indicated that the
pathogenicity of RVFV in the dromedary camels has
not been investigated sufficiently. To advance beyond
the current knowledge of the epidemiology of the dis-
ease, we conducted this study to determine the preva-
lence of RVF and associated risk factors among camels
in Khartoum, Sudan, the second largest producing
camel region in the world.
In epidemiological surveys, high prevalence rates of
45 % and 38.5 % for RVFV seropositivity were reported
among camels in Tanzania and Mauritania, respectively
[26, 27]. In Niger, high prevalence rate of RVFV
Table 1 Univariate analysis for the association between potential
risk factors and RVF seropositivity among camels in Khartoum






Locality 3 0.48 0.37
East Nile 60 8 (13.3 %)
Bahry 60 4 (6.7 %)
Omdurman 60 7 (11.7 %)
Ombadda 60 4 (6.7 %)
Age 1 0.03 0.031
Small 53 1 (1.9 %)
Old 187 22 (11.8 %)
Sex 1 0.70 0.48
Female 202 20 (9.9 %)
Male 38 3 (7.9 %)
Breed 2 0.78 0.82
Western 116 12 (10.3 %)
Anafi 19 1 (5.3 %)
Bushari 105 10 (9.5)
Body condition 2 0.35 0.80
Emaciation 3 1 (33.3 %)
Thin 82 7 (8.5 %)
Fat 155 15 (9.7)
Farm yard 1 0.085 0.065
In door 126 16 (12.7 %)
Out door 114 7 (6.1 %)
Grazing system 1 0.73 0.48
Stationary 181 18 (9.9 %)
Nomadic 59 5 (8.5 %)
Herd size 2 0.69 0.47
Small 28 2 (7.1 %)
Medium 19 1 (5.3 %)
Large 193 20 (10.4 %)
Mosquitoes present 1 0.063 0.047
No 84 4 (4.8 %)
Yes 156 19 (12.2 %)
Mosquitoes control 1 0.78 0.518
No 193 19 (9.8 %)
Yes 47 4 (8.5 %)
Rain fall 1 0.008 0.005
Low 93 3 (3.2 %)
High 147 20 (13.6 %)
Vegetation 1 0.35 0.24
Low 124 14 (11.3 %)
High 116 9 (7.8 %)
Table 1 Univariate analysis for the association between potential
risk factors and RVF seropositivity among camels in Khartoum
State of Sudan using Chi-square test (Continued)
Water bond 1 0.18 0.13
No 125 15 (12 %)
Yes 115 8 (7 %)
Table 2 Multivariate analysis, using logistic regression model,
for significant association (p > 0.05) of risk factors and RVF
seropositivity among camels in Khartoum State, Sudan
Risk factors OR 95 % C I P-Value
Age
Small Reference 1.05–9.65.35 0.04
Old 8.29
Rain fall
Low Reference 1.46–19.66 0.01
Heavy 5.36
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seropositivity of 47.5 % was also reported in camels in
some region of the country [34]. In Nigeria, earlier
serological surveys indicated that RVF infection is gen-
erally widespread among camels with a prevalence rate
of 3.3 % [19]. In the present study, the seroprevalence
of RVFV-specific antibodies in camels of Khartoum
State (9.6 %) is markedly higher than previously re-
ported prevalence rates in other states of Sudan [12].
The high seroprevalence rate of RVFV in Khartoum
could be attributed to newly constructed irrigation
projects and agricultural scheme in the region, which
might contribute in suitable climatic condition for sur-
vival of the adults and larvae of Aedes vectors in this
region [35, 36]. In addition, the heavy rainfall associ-
ated with the large RVF outbreaks in Sudan 2007 and
2010 were suggested to contribute to high prevalence
of RVF among the Sudanese dromedary camel [1, 28].
The circulation of RVFV in the country and the risks
these infected camels pose for highly susceptible young
ruminants necessitates the importance of improved
surveillance system for this viral pathogen in Sudan.
The RVF seropositivity increased with older age in the
studied herds. When assessing age as a risk factor,
there was a significant association between RVFV in-
fection rate and increasing age of the animal. It was
shown that the camels started to get infected with
RVFV after the age of 2 years. At this age, the animals
are usually released into the pasture for grazing, where
they are likely to be exposed to infected mosquitoes
and subsequent RFV infection. We believe that the
association of RVF and age is probably attributed to
frequent exposure of older camels to the mosquito
vectors. Young camels (<2 years) are usually kept in-
doors and are well taken care of by the animal owners
from contracting infectious diseases, particularly the
insect and tick-borne infections. Our result is in agree-
ment with previous epidemiological surveys, which re-
ported higher risks of older camels for RVF infections
[19, 27, 37]. It should be noted that the RVFV-specific
antibodies detected among camels in Khartoum State
indicated natural infection as vaccination is not prac-
ticed in the country for this animal species. In addition,
all camels included in this study were aged over one
year. Therefore, it is assumed that maternal antibodies
were no longer persisted and that antibody indicated
natural infection with RVF.
Heavy rainfall is another potential risk factor that
affects RVFV seropositivity among camels in Khartom
State. Our result is in agreement with that of the study
conducted by other workers who reported association
between RVF seropositivity and rainfall [24, 25]. The role
of the international trade of livestock in dissemination of
animal diseases should not be neglected. In this regard,
live camels are exported to Egypt, from Sudan as a source
of meat, for human consumption. Therefore, identifica-
tion of the genetic lineage of RVFV strains circulating in
a particular location would be important to follow the
movement of the virus within and outside the African
continent [1, 38–40].
In contrast, the risk assessment studies indicated that
there was no significant association between RVF sero-
positivity and the rest of the individual or management
risk factors included in the study. There was no signifi-
cant difference between localities regarding RVF sero-
positivity in camels. In addition, there was no significant
association between mosquito control and RVF seroposi-
tivity among camels suggesting failure of the control
program against RVF in Khartoum State. Highest and
lowest rates of RVFV infections were recorded in Sherq
Elnile and Omdurman localities, respectively.
Conclusions
The study provides evidence of circulation of RVFV
among camels in Khartoum State, Sudan, as determined
by the presence of RVFV-specific IgG antibodies using
cELISA. It is recommended that further study should
be conducted in sentinel camel herds to determine the
incidence of new cases and to conduct RVF virus isola-
tion attempts. Any recovered RVFV strains should be
employed to determine the virus whole genome sequence
and to identify the genetic lineage of the virus circulating
among camels in Khartoum State. Surveillance for RVF
in domestic livestock and studies on distribution of the
mosquito vectors should continue to provide public health
authorities an opportunity to anticipate and prepare for a
possible RVF outbreak in Khartoum State, Sudan.
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